5-(1,1,1-Trifluoro-2-methylpropan-2-yl)isoxazol-3-amine

Catalog No. :
ACPWEU246
CAS No. :
1188911-74-1
Molecular Formula :
C7H9F3N2O
Molecular Weight :
194.16

IUPAC Name:5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-amine

5-(1,1,1-Trifluoro-2-methylpropan-2-yl)isoxazol-3-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$134.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(1,1,1-Trifluoro-2-methylpropan-2-yl)isoxazol-3-amine
IUPAC Name5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-amine
MDL No.MFCD23106060
Molecular FormulaC7H9F3N2O
Molecular Weight194.16
SMILESNC1=NOC(C(C)(C)C(F)(F)F)=C1
InChI KeyTWCGWZZURUKYJS-UHFFFAOYSA-N
Synonym5-(1,1,1-Trifluoro-2-methylpropan-2-yl)isoxazol-3-amine;5-(1,1,1-Trifluoro-2-methylpropan-2-yl)-1,2-oxazol-3-amine;3-Amino-5-(1,1,1-trifluoro-2-methyl-2-propyl)isoxazole;3-Isoxazolamine, 5-(2,2,2-trifluoro-1,1-dimethylethyl)-;5- (1,1,1-trifluoro-2-methylpropyl-2-yl) isoxazol-3-amine;5-(2,2,2-Trifluoro-1,1-dimethyl-ethyl)-isoxazol-3-ylamine
CAS No.1188911-74-1

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACPWEU246 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPWEU246 route product structure diagram
    ACPWEU2461188911-74-1 In Stock
Inquiry

2. ACPWEU246 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPWEU246 route product structure diagram
    ACPWEU2461188911-74-1 In Stock
Inquiry

Comments (0)